Cancer

Second opinion at RUSH helped Lynn Stewart overcome advanced heart failure, return to the activities she enjoys

Jessica Slostad, MD, is an assistant professor of Medicine in the Division of Hematology, Oncology and Cellular Therapy at RUSH and specializes in breast cancer management. Her research interests include clinical and translational research with a focus on precision oncology and organoid technology.

How Wanda Veld overcame an aggressive cancer after more than a decade of treatment

Over more than four decades, Patty Piasecki, NP, has played a critical role at RUSH — supporting leading-edge cancer research and care

Diagnosed with lung cancer at age 28, Aurora Lucas now advocates for others with the disease

As a complement to oncology care, aromatherapy can help with anxiety, nausea and pain

How sustainability was a priority in the new outpatient facility

Ganesh Pai considers Swim Across America, RUSH support a ‘thank you’ for wife’s cancer treatment

How the artwork in the new building promotes hope and healing

Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.